# |
Query |
Results |
S33 |
S20 AND S32 |
37 |
S32 |
S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 |
1,053,818 |
S31 |
TX allocat* random* |
5,059 |
S30 |
(MH "Quantitative Studies") |
14,585 |
S29 |
(MH "Placebos") |
9,730 |
S28 |
TX placebo* |
38,559 |
S27 |
TX random* allocat* |
5,059 |
S26 |
(MH "Random Assignment") |
41,063 |
S25 |
TX randomi* control* trial* |
105,940 |
S24 |
TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) |
835,812 |
S23 |
TX clinic* n1 trial* |
186,430 |
S22 |
PT Clinical trial |
79,707 |
S21 |
(MH "Clinical Trials+") |
198,930 |
S20 |
S11 AND S19 |
94 |
S19 |
S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 |
4,335 |
S18 |
TX embryo* N3 transfer* |
913 |
S17 |
TX ovar* N3 hyperstimulat* |
381 |
S16 |
TX ovari* N3 stimulat* |
300 |
S15 |
TX IVF or TX ICSI |
1,559 |
S14 |
(MM "Fertilization in Vitro") |
1,611 |
S13 |
TX vitro fertilization |
3,319 |
S12 |
TX vitro fertilisation |
3,319 |
S11 |
S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 |
1,349 |
S10 |
TX LH supplement* |
7 |
S9 |
TX recombinant LH |
6 |
S8 |
TX recombinant human LH |
3 |
S7 |
TX (recLH or rhlh) |
1 |
S6 |
TX (r‐hlh or r‐LH) |
3 |
S5 |
TX pergonal |
3 |
S4 |
TX lutropin |
7 |
S3 |
TX luteini?ing hormone |
1,307 |
S2 |
TX (rLH or rec LH) |
37 |
S1 |
(MM "Luteinizing Hormone") |
164 |